Showing results (161-170 of 240) with videos related to

Sort By:
Pageof 24
Cancers|September 19, 2020
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical TrialsTimothy A Lin, Clifton David Fuller, Vivek Verma, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancerAwalpreet S Chadha, Esengul Kocak-Uzel, Prajnan Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warrantedJosé G Guillem, Juan A Díaz-González, Bruce D Minsky, et al.
Technical Innovations & Patient Support in Radiation Oncology|October 15, 2024
Evaluating pre-consult patient education videos for patients with newly-diagnosed anal squamous cell carcinoma: Impact on patient comprehension, satisfaction and distressKelsey L Corrigan, Lauren M Andring, Prajnan Das, et al.
Clinical Colorectal Cancer|February 7, 2022
Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local RecurrenceZooha Khan, Michael K Rooney, Prajnan Das, et al.
Mayo Clinic Proceedings|February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled TrialsDario Pasalic, C David Fuller, Walker Mainwaring, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2005
The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European ConsensusVincenzo Valentini, Bengt Glimelius, Bruce D Minsky, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombusEmma B Holliday, Randa Tao, Zachary Brownlee, et al.
Surgery Today|May 16, 2020
Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cellsKazuto Harada, Madhavi Patnana, Xuemei Wang, et al.
Annals of Surgical Oncology|April 9, 2011
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysisTobias Leibold, Timothy J Akhurst, David B Chessin, et al.
Pageof 24